MICARI, Antonio
 Distribuzione geografica
Continente #
EU - Europa 5.160
NA - Nord America 4.649
AS - Asia 3.179
SA - Sud America 1.415
AF - Africa 129
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.537
Nazione #
US - Stati Uniti d'America 4.520
RU - Federazione Russa 2.176
SG - Singapore 1.595
BR - Brasile 1.270
IE - Irlanda 932
SE - Svezia 563
IT - Italia 556
HK - Hong Kong 505
CN - Cina 488
DE - Germania 230
VN - Vietnam 172
IN - India 127
FI - Finlandia 125
GB - Regno Unito 110
PL - Polonia 102
FR - Francia 76
AT - Austria 70
CA - Canada 60
AR - Argentina 57
UA - Ucraina 54
MX - Messico 45
ES - Italia 39
TR - Turchia 39
NL - Olanda 38
ZA - Sudafrica 34
BD - Bangladesh 33
MA - Marocco 31
UZ - Uzbekistan 30
EG - Egitto 27
JP - Giappone 27
EC - Ecuador 26
IQ - Iraq 24
PK - Pakistan 22
BE - Belgio 18
ID - Indonesia 15
CO - Colombia 14
VE - Venezuela 14
AZ - Azerbaigian 13
CZ - Repubblica Ceca 12
LT - Lituania 12
AE - Emirati Arabi Uniti 11
IL - Israele 10
PY - Paraguay 10
KZ - Kazakistan 9
TN - Tunisia 9
PE - Perù 8
DZ - Algeria 7
BO - Bolivia 6
CL - Cile 6
KE - Kenya 6
LB - Libano 6
SN - Senegal 6
AL - Albania 5
JO - Giordania 5
NP - Nepal 5
PA - Panama 5
AM - Armenia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
OM - Oman 4
PT - Portogallo 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
CI - Costa d'Avorio 3
CY - Cipro 3
DK - Danimarca 3
GT - Guatemala 3
HN - Honduras 3
LV - Lettonia 3
NO - Norvegia 3
PH - Filippine 3
QA - Qatar 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TJ - Tagikistan 3
AO - Angola 2
CR - Costa Rica 2
EE - Estonia 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AU - Australia 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
Totale 14.529
Città #
Moscow 1.140
Dublin 932
Ashburn 811
Dallas 739
Singapore 736
Chandler 505
Hong Kong 501
Nyköping 310
Beijing 185
Messina 183
Los Angeles 173
Princeton 121
The Dalles 116
Medford 113
New York 107
Jacksonville 106
São Paulo 106
Munich 102
Warsaw 93
Des Moines 82
Pune 78
Ho Chi Minh City 67
Buffalo 65
Redondo Beach 60
Rome 41
Vienna 41
Helsinki 38
Hanoi 37
Rio de Janeiro 36
Belo Horizonte 35
Turku 35
Nuremberg 34
Boardman 32
Brooklyn 31
Ann Arbor 29
Montreal 29
Milan 28
Tashkent 28
Tianjin 28
Wilmington 28
Chicago 27
Council Bluffs 25
Tokyo 25
Johannesburg 24
London 23
Boston 22
Cambridge 22
Catania 22
Chennai 22
Amsterdam 20
Curitiba 20
Dearborn 20
Düsseldorf 20
Santa Clara 20
Frankfurt am Main 19
Phoenix 19
Stockholm 19
Brussels 18
Denver 18
Lappeenranta 18
Lauterbourg 18
Brasília 17
Porto Alegre 17
San Francisco 17
Seattle 17
Campinas 16
Manchester 16
Orem 16
Salvador 16
Ankara 15
Poplar 15
Palermo 14
Baku 13
Bremen 13
Guarulhos 13
Nanjing 13
Washington 13
Dong Ket 12
Houston 12
Jinan 12
Cairo 11
Goiânia 11
Manaus 11
Mexico City 11
Baghdad 10
Haiphong 10
San Jose 10
Shanghai 10
Atlanta 9
Duque de Caxias 9
Fortaleza 9
Guayaquil 9
Jakarta 9
Lahore 9
Quito 9
Taizhou 9
Tel Aviv 9
Bexley 8
Casablanca 8
Haikou 8
Totale 8.868
Nome #
754 Non-conducted premature atrial complexes: a new predictor for atrial fibrillation in cryptogenic stroke patients 162
Anatomical M-mode: An old-new technique 157
686 Coronary lesion distribution in young patient presenting with acute coronary syndrome 152
Ruolo della seconda armonica tissutale durante eco-dobutamina. 149
752 Acute coronary syndrome in young patients: long-term follow-up and quality of life assessment 146
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management 141
A Very Late Atrial Septal Erosion After an Ostium Secundum Percutaneous Closure 139
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 137
Behavior of both epicardial and intramural coronary artery flow velocities in various models of myocardial hypertrophy: Role for left ventricular outflow tract obstruction 135
Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value 135
Non-conducted premature atrial complexes: A new independent predictor of atrial fibrillation in cryptogenic stroke 132
Asymptomatic Left Ventricular Dysfunction: Is There a Role for Screening in General Population? 130
609 Multimodality imaging for definition and treatment selection of multiple coronary aneurysms 127
Coronary-subclavian steal phenomenon late after coronary artery bypass grafting: an underappreciated cause of myocardial ischemia? 126
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 125
Caratterizzazione mediante ecocardiografia trantoracica del flusso coronarico intramurale nella cardiomiopatia ipertrofica con e senza ostruzione dinamica. 125
Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The Chronic Total Occlusion Cohort in the IN.PACT Global Study 122
A Systematic Review and Meta-Analysis Including 354 Patients from 13 Studies of Intravascular Lithotripsy for the Treatment of Underexpanded Coronary Stents 120
2-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study 119
CARDIAC AND VASCULAR IMPAIRMENT IN PATIENTS WITH MILD PSORIASIS: A LONGITUDINAL STUDY 116
A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study 115
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 114
Constrictive Pericarditis: An Update on Noninvasive Multimodal Diagnosis 113
Acute and 30-Day Safety and Effectiveness Evaluation of Eximo Medical's B-Laser™, a Novel Atherectomy Device, in Subjects Affected With Infrainguinal Peripheral Arterial Disease: Results of the EX-PAD-03 Trial 113
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways 112
Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis 111
Global cardiovascular assessment in patients with PH+ chronic myeloid leukaemia treated with TKI: long-term follow-up 110
3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO) 107
Advanced echocardiographic analysis to identify cardiac toxicity after TKI exposure in patients with CML 107
2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease 106
Non-invasive assessment of myocardial work: an useful tool for predicting LV remodelling after myocardial infarction? 103
Non-transmural myocardial infarction associated with regional contractile function is an independent predictor of positive outcome: an integrated approach to myocardial viability 102
PROGNOSTIC VALUE OF TWO DIMENSIONAL STRAIN IN EARLY ISCHEMIC HEART DISEASE: A 5-YEAR FOLLOW-UP STUDY 101
Valutazione ecocardiografica transtoracica dei vasi coronarici intramiocardici ed implicazioni fisiopatologiche nella cardiomiopatia ipertrofica 100
Eco TEE sempre prima della cardioversione per fibrillazione atriale 100
 Stress echocardiography: myocardial work ‘works’ 98
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels 97
Which is the best Myocardial Work index for the prediction of coronary artery disease? A data meta-analysis 96
Atypical presentation of Takotsubo syndrome early after pacemaker implantation 96
Caratterizzazione mediante ecocardiografia transtoracica del flusso coronarico intramurale nella cardiomiopatia ipertrofica con e senza ostruzione dinamica 95
Systolic wall stress may affect the intramural coronary blood flow velocity in myocardial hypertrophy, independently on the left ventricular mass 95
First Lotus aortic valve-in-valve implantation to treat degenerated Mitroflow bioprostheses 94
High mean wall stress affects the intramural coronary artery blood flow velocity in left ventricular hypertrophy, independently on the left ventricular mass 93
Thrombo-embolic risk evaluation in patients with atrial fibrillation. Role of echocardiography 93
DAL COMPASS AI DATI DI REAL LIFE: UNO STUDIO CASO-CONTROLLO 92
MYOCARDIAL INFARCTION AND STROKE IN A YOUNG PATIENT AFFECTED BY LES: KEY ROLE OF AN INTEGRATED IMAGING APPROACH 92
A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: Acute and midterm results 92
5-Year Outcomes of Drug-Coated Balloons for Peripheral Artery In-Stent Restenosis, Long Lesions, and CTOs 91
Current options and recommendations for the use of thoracic endovascular aortic repair in acute and chronic thoracic aortic disease: an expert consensus document of the European Society for Cardiology (ESC) Working Group of Cardiovascular Surgery, the ESC Working Group on Aorta and Peripheral Vascular Diseases, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Association for Cardio-Thoracic Surgery (EACTS) 91
Anti-inflammatory and pro-angiogenic effects of beta blockers in a canine model of chronic ischemic cardiomyopathy: Comparison between carvedilol and metoprolol 90
Which is the best myocardial work index for the prediction of coronary artery disease? a data metanalysis 89
Cough, a rare and not well recognized symptom of lead perforation 88
High mean wall stress affects the intramural coronary artery blood flow velocity in left ventricular hypertrophy, independently on the left ventricular mass 88
Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study 88
ANOMALOUS ORIGIN OF LEFT CIRCUMFLEX ARTERY FROM RIGHT SINUS OF VALSALVA: A RARE CASE BUT WITH GREAT CLINICAL RELEVANCE 87
Analysis of changes in "mitral valve reserve" after coronary artery bypass grafts in patients with functional mitral regurgitation 87
Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management—A Narrative Review 87
The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes 87
Needle-Delivered Drug Elution in Femoral Artery Disease ∗ 86
PSEUDO-MOBITZ VAGAL ATRIOVENTRICULAR BLOCK: TWO CASE REPORTS IN YOUNG HEALTHY MEN 85
Diversa risposta riperfusiva alla terapia fibrinolitica dei pazienti diabetici con infarto miocardico acuto 85
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis 84
Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study 84
Percutaneous Coronary Intervention before or after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Involving 1531 Patients 83
Chest Pain and the Dynamic Evolution of Spontaneous Coronary Artery Hematoma 82
Paclitaxel exposure: Long-term safety and effectiveness of a drug-coated balloon for claudication in pooled randomized trials 82
Cardiac Involvement of Metastatic Clear Cell Sarcoma: A Multimodality Imaging Report 81
A Multimodality Imaging for Definition and Treatment Selection of Multiple Coronary Aneurysms: A Case Report and Review of the Literature 81
IL RISCONTRO DI VITALITÀ PUÒ PREDIRE L’OUTCOME? 81
A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The bello (balloon elution and late loss optimization) study 81
FAILURE OF RYTHMIQ, AN ALGORITHM FAVOURING INTRINSIC CONDUCTION: WHEN IS TOO MUCH OF A GOOD THING? 81
Alcohol septal ablation: An option on the rise in hypertrophic obstructive cardiomyopathy 80
Echocardiographic Evolution of PosteroLateral Left Ventricular Aneurysm with Normal Coronary Arteries in Patient Recently COVID-19 Vaccinated: A Complicated Atypical Case of Takotsubo Syndrome Vaccine-related? 80
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 80
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 79
Clinical outcome after interventions with paclitaxel-coated balloons: A PCR statement 79
Looking 'behind': coronary left main compression by a large aortic pseudoaneurysm 79
Mid-ventricular paradoxical dynamic obstruction in a right-sided secondary hypertrophic cardiomyopathy 78
Similarities and Differences Between Primary Percutaneous Coronary Intervention and Mechanical Thrombectomy 78
The cardio‑vascular future of panvascular medicine: The basics 78
The year in cardiology 2016: Peripheral circulation 78
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation 78
1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease 77
Mental health status and sexual habits in young patient after acute coronary syndrome 77
The Role of Imaging in Cardiovascular Prevention: A Comprehensive Review 76
Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study 75
Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort 75
Intramyocardial coronary flow velocity in patients with various types of cardiac hypertrophy 74
Contrast echocardiography: basic principles, current clinical use and future perspectives 73
Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions: Five-Year Outcomes from the IN.PACT SFA Randomized Trial 73
Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon 73
David versus goliath: The first round 73
Update on the TURBO BOOSTER spectranetics laser for lower extremity occlusive disease 73
Response by Schneider et al to Letter Regarding Article, "treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial" 73
Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study 73
Lipomatous Hypertrophy of the Interatrial Septum: A Case Report and Insights from the Literature 72
Relationship between pulse wave velocity and myocardial work in untreated hypertensive patients with preserved left ventricle ejection fraction. 72
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management 71
Clinical Applications of Myocardial Work in Echocardiography: A Comprehensive Review 71
Distribution of wall motion abnormalities in young patients presenting with acute coronary syndrome 71
Totale 9.680
Categoria #
all - tutte 58.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.799


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021291 0 0 0 0 0 38 28 57 108 30 7 23
2021/2022766 2 46 27 13 55 18 49 27 9 136 50 334
2022/20232.206 180 166 83 137 94 232 41 147 1.014 15 64 33
2023/2024848 48 95 69 87 45 218 50 37 42 49 5 103
2024/20254.065 60 34 42 313 205 200 144 901 958 226 346 636
2025/20266.312 702 703 861 750 860 2.436 0 0 0 0 0 0
Totale 14.970